Knowledge of major equipment, instruments, plants, and sterile production environments, including facilities, utilities, and equipment.
Proficiency using measurement instruments for physical quantities and the sample instrumentation required for qualification, validation, and calibration activities.
Knowledge of technical documentation, including P&IDs, electrical diagrams, layouts, and technical data sheets; validation protocols for different equipment types; test instrumentation; and metrology concepts.
Knowledge of computer systems for controlling, operating, and monitoring plants, electronic data archiving, Building Management Systems (BMS), SCADA, highly automated systems, and SAP.
Good knowledge of English.
At least two years of experience in the role and in pharmaceutical validation and equipment, including knowledge of fundamental GMP requirements.
Practical ability to solve problems in the field.
Responsibilities
Support the Contract Coordinator with activities related to the contract.
Perform technical qualification, validation, and calibration of instruments and equipment used in pharmaceutical manufacturing processes.
Write, execute, and complete qualification and validation tests and protocols.
Complete and review test reports.
Calibrate and certify measuring instruments used in manufacturing processes.
Use reference instrumentation to measure and monitor physical parameters and perform qualification and validation tests.
Perform environmental monitoring tests and thermal mapping.
Collaborate with the validation and calibration team and the client's internal engineering, maintenance, qualification, and QA departments.
Descrizione del lavoro
La nuova risorsa farà parte del team a supporto del Contract Coordinator e lo supporterà nelle seguenti attività inerenti la commessa:
esecuzione tecnica di attività di qualifica, convalida e calibrazione di strumenti e apparecchiature, nell’ambito di processi produttivi settore farmaceutico.
Nello specifico, si occuperà di:
Redazione/scrittura, Esecuzione e compilazione test e protocolli di qualifica/convalida
Compilazione/Revisione Test Report
Taratura e certificazione di strumenti di misura utilizzati nei processi produttivi
Utilizzo di strumentazione campione per la rilevazione misurazione e controllo di parametri fisici e per l’esecuzione di test di qualifica/convalida
Esecuzione test di monitoraggi ambientali, mappature termiche,
Collaborazione con il team di validazioni/calibrazioni, con i reparti interni del cliente di Ingegneria, Manutenzione, qualifiche, QA,
Qualifiche
Conoscenze delle principali apparecchiature, strumentazione, impianti e ambienti di produzione sterile, Facilities/Utilities /Equipment
Conoscenza / Padronanza nell’uso di strumenti di misura per grandezze fisiche della principale strumentazione campionenecessaria per le attività di Qualifica, Convalida e Calibrazione.
Conoscenza di Documentazione tecnica (P&ID, schemi elettrici, layout, schede tecniche), Protocolli di convalida per diverse tipologie di apparecchiature, Strumentazione di prova e concetti di metrologia
Conoscenza sistemi informatici per il controllo conduzione e monitoraggio di impianti, archiviazione elettronica dei dati, Building Management System (BMS), SCADA, sistemi ad elevata Automazione, sistema SAP
Buona conoscenza della lingua inglese
Maturata esperienza nel ruolo, almeno due anni , e nel campo della validazione ed equipment farmaceutici nell'ambito dei fondamentali requisiti GMP
Abilità pratica nel risolvere problemi sul campo
Capacità di collaborare efficacemente con i colleghi
Attitudine al lavoro di squadra e alla comunicazione chiara
Attenzione alle esigenze dei clienti e dei colleghi
Informazioni aggiuntive
Cosa offriamo:
Contratto di lavoro a Tempo indeterminato
Range retributivo annuale tra €25000 e €30000 in base all'effettiva esperienza maturata
Ticket
Cellulare aziendale
Fondo pensione complementare e copertura sanitaria
As an inclusive company, Veolia is committed to diversity and gives equal consideration to all applications, without discrimination.
Veolia has completed a €1.15 billion senior bond offering across two tranches. The issuance comprises €650 million with a four-year maturity at a 3.678% coupon and €500 million with an eight-year maturity at a 4.088% coupon.
The transaction attracted over 250 orders totalling €3.4 billion. The public services group said the substantial oversubscription, investor quality and favourable terms reflect positive market perception of Veolia's credit profile and international growth prospects, as well as its financial strength.
Veolia Environnement reported revenue of €22.93 billion for the first half of 2026, up 1.5% at constant scope and foreign exchange, excluding energy prices. The company's EBITDA reached €3.55 billion, rising 5% with margins improving by 70 basis points to 16%.
Current net income grew 10.4% at constant scope and forex, whilst net free cash flow improved by €164 million compared to the same period in 2025. The company achieved €195 million in efficiency gains during the period.
Veolia completed its acquisition of Cleaners in the United States, which contributed to net financial debt of €24.5 billion. The company raised its full-year 2026 current net income growth guidance to at least 8%, citing strong operational performance and well-controlled financial charges.
Revenue growth in water technology faced temporary delays in the Middle East due to geopolitical tensions.
Veolia Environnement has launched a €400 million offering of non-dilutive cash-settled convertible bonds due January 2032. The bonds will be offered exclusively to qualified institutional investors through an accelerated bookbuilding process.
The synthetic convertible bonds offer exposure to Veolia's share performance but will be cash-settled only, without issuing new shares. The bonds will bear an annual interest rate between 0.50% and 0.75%, with a conversion premium of 20% over a reference share price. Concurrently, Veolia will purchase cash-settled call options to hedge its exposure.
The company intends to use proceeds for general corporate purposes, including purchasing the options. BNP Paribas and Natixis serve as joint global coordinators, with BofA Securities, Citigroup and Morgan Stanley as joint bookrunners. Veolia plans to list the bonds on Euronext Access within 30 days.
Veolia Environnement has completed a convertible bond offering worth €700 million through private placement without shareholders' preferential subscription rights. The bonds are convertible and exchangeable for new or existing shares, due 15 March 2021.
Natixis served as joint global coordinator and joint bookrunner for the transaction, marking the firm's fourth convertible bond of the year. The net proceeds will refinance an outstanding convertible bond due in 2021.
The issuance demonstrates investor confidence in Veolia's financial stability following its integration of Suez and ongoing business portfolio transformation. The transaction supports the company's GreenUp strategic plan focused on sustainable growth and ecological transformation.
New Enviri has launched as a standalone public company following the completion of Clean Earth's sale to Veolia Environnement. The company, led by President and CEO Russell Hochman, provides environmental solutions for industrial waste streams and rail sector equipment and technology.
Enviri shareholders received one share of New Enviri common stock for every three shares of Enviri common stock, plus cash per share. Regular Way trading began on 2 June 2026 under the ticker "NVRI" on the New York Stock Exchange.
New Enviri expects annualised 2026 pro forma revenues of approximately $1.2 billion and adjusted EBITDA of $140 million. The company has a net debt to adjusted EBITDA ratio of 2.0x and an undrawn revolving credit facility at closing.